Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?

被引：0

作者：

I. Watermann

B. Schmitt

F. Stellmacher

J. Müller

R. Gaber

Ch. Kugler

N. Reinmuth

R. M. Huber

M. Thomas

P. Zabel

K. F. Rabe

D. Jonigk

A. Warth

E. Vollmer

M. Reck

T. Goldmann

机构：

[1] Clinical and Experimental Pathology,

[2] Research Center Borstel,undefined

[3] LungenClinic Grosshansdorf,undefined

[4] Airway Research Center North (ARCN),undefined

[5] Member of the German Center for Lung Research (DZL),undefined

[6] Ludwig Maximilians University (LMU),undefined

[7] Comprehensive Pneumology Center Munich,undefined

[8] (CPC-M),undefined

[9] Member of the German Center for Lung Research,undefined

[10] Thoracic Oncology Centre Munich,undefined

[11] Medical Clinic,undefined

[12] Research Center Borstel,undefined

[13] Institute of Pathology,undefined

[14] Hannover Medical School,undefined

[15] Biomedical Research in Endstage and Obstructive Lung Disease Hanover (BREATH),undefined

[16] Member of the German Center for Lung Research,undefined

[17] Institute of Pathology,undefined

[18] Heidelberg University,undefined

[19] Translational Lung Research Center (TLRC),undefined

[20] Member of the German Center for Lung Research,undefined

[21] Pathology,undefined

[22] Faculty of Medicine,undefined

[23] Alexandria University,undefined

来源：

Diagnostic Pathology | / 10卷

关键词：

Non-small cell lung Cancer (NSCLC); MET; Targeted therapies; Diagnostic; Phosphorylated MET; Immunohistochemistry; Fluorescence in situ hybridization;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[11] Analysis of c-Met gene amplification in Japanese patients with advanced non-small cell lung cancer (NSCLC)
Sone, T.
Kasahara, K.
Sakai, A.
Ikeda, H.
Kurokawa, K.
Fujimura, M.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[12] ANALYSIS OF C-MET GENE AMPLIFICATION IN JAPANESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Sone, Takashi
Matsui, Tomohiro
Kurokawa, Kouji
Sakai, Asao
Kasahara, Kazuo
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S462 - S462
[13] C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer
Tsakonas, G.
Hirsch, F. R.
Ekman, S.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2124 - S2125
[14] c-MET as a biomarker in patients with surgically resected non-small cell lung cancer
Tsakonas, Georgios
Botling, Johan
Micke, Patrick
Rivard, Chris
LaFleur, Linnea
Mattsson, Johanna
Boyle, Teresa
Hirsch, Fred R.
Ekman, Simon
LUNG CANCER, 2019, 133 : 69 - 74
[15] The role of HGF/C-met signalling pathway on the non-small cell lung cancer
Gumustekin, M.
Sis, B.
Bulut, G.
Kargi, A.
Oztop, I.
Olgun, N.
Atabey, N.
FEBS JOURNAL, 2006, 273 : 89 - 89
[16] PROTEASOME INHIBITORS REDUCE C-MET IN NON-SMALL CELL LUNG CANCER CELLS
Li, Yanhui
Dong, Su
Tamaskar, Arya
Wang, Heather
Zhao, Jing
Zhao, Yutong
JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (05) : 1117 - 1118
[17] HGF/c-Met Overexpressions, but not Met Mutation, Correlates with Progression of Non-small Cell Lung Cancer
Gumustekin, Mukaddes
Kargi, Aydanur
Bulut, Gulay
Gozukizil, Aysim
Ulukus, Cagnur
Oztop, Ilhan
Atabey, Nese
PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (02) : 209 - 218
[18] Mechanism of EGFR and c-Met TKI resistance and role of co-expression of EGFR and c-Met in non-small cell lung cancer patients
Botting, Gregory Michael
Harrington, Kymberly
Shearrow, Caleb
Crees, Zachary
Girard, Jennifer
Arasi, Kavin
Puri, Neelu
CANCER RESEARCH, 2014, 74 (19)
[19] Proteasome Inhibitors Diminish c-Met Expression and Induce Cell Death in Non-Small Cell Lung Cancer Cells
Li, Yanhui
Dong, Su
Tamaskar, Arya
Wang, Heather
Zhao, Jing
Ma, Haichun
Zhao, Yutong
ONCOLOGY RESEARCH, 2020, 28 (05) : 497 - 507
[20] Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer
Han, Zhaoguo
Xiao, Yadi
Wang, Kai
Yan, Ji
Xiao, Zunyu
Fang, Fang
Jin, Zhongnan
Liu, Yang
Sun, Xilin
Shen, Baozhong
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (11) : 1686 - 1691

← 1 2 3 4 5 →